help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kerstjens, H. A.
Right arrow Articles by Postma, D. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kerstjens, H. A.
Right arrow Articles by Postma, D. S.

Am. J. Respir. Crit. Care Med., Vol 151, No. 2, Feb 1995, 360-368.

Importance of total serum IgE for improvement in airways hyperresponsiveness with inhaled corticosteroids in asthma and chronic obstructive pulmonary disease. The Dutch CNSLD Study Group

HA Kerstjens, JP Schouten, PL Brand, DF Schoonbrood, PJ Sterk and DS Postma
Department of Pulmonary Medicine, University Hospital Groningen, The Netherlands.

Airways hyperresponsiveness is a hallmark of asthma, and many patients with COPD also demonstrate hyperresponsiveness. Inhaled corticosteroids improve hyperresponsiveness, but the extent of improvement may vary considerably between patients. This study was designed to determine which patient characteristics predict these differences in response. Patients with mild to moderately severe obstructive airways disease (asthma and COPD) were selected if PC20 < or = 8 mg/ml and FEV1 < 95% confidence interval of predicted normal. They were followed for 2.5 yr, during which one-third received inhaled corticosteroids. The independent influences of baseline FEV1/IVC, bronchodilator response, PC20, smoking habits, allergy, age, and sex on the improvement in airways hyperresponsiveness with inhaled corticosteroids were analyzed. Total serum IgE was taken as a parameter of allergy, next to specific IgE for house dust mite, skin tests, and blood eosinophils. Total serum IgE was found to be the most important and single independent predictor of change in PC20 with inhaled corticosteroids: patients with a higher IgE had a greater increase in PC20 when administered inhaled corticosteroids than those with lower IgE levels. Alternatively, patients with a higher IgE who did not receive corticosteroids had a decrease in PC20 compared with patients with a lower IgE. This effect was most prominent in asthma but was inconsistent in asthmatic bronchitis and COPD. The level of IgE cannot be used to predict the response to inhaled corticosteroids in individuals accurately. Total serum IgE is the single most important predictor of change in PC20 with and without inhaled corticosteroids.(ABSTRACT TRUNCATED AT 250 WORDS)


This article has been cited by other articles:


Home page
Therapeutic Advances in Respiratory DiseaseHome page
G. Braganza, R. Chaudhuri, and N. C. Thomson
Review: Treating patients with respiratory disease who smoke
Therapeutic Advances in Respiratory Disease, April 1, 2008; 2(2): 95 - 107.
[Abstract] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
Y. Y. Koh, M. H. Lee, Y. H. Sun, Y. Park, and C. K. Kim
Improvement in Bronchial Hyperresponsiveness with Inhaled Corticosteroids in Children with Asthma: Importance of Family History of Bronchial Hyperresponsiveness
Am. J. Respir. Crit. Care Med., August 1, 2002; 166(3): 340 - 345.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
Y. Y. Koh, Y. H. Sun, H. S. Lim, C. K. Kim, and S. J. Hong
Effect of Inhaled Budesonide on Bronchial Hyperresponsiveness in Adolescents With Clinical Remission of Asthma
Chest, October 1, 2001; 120(4): 1140 - 1146.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
D. G. Rudmann, M. W. Moore, J. S. Tepper, M. C. Aldrich, J. W. Pfeiffer, H. Hogenesch, and D. B. Tumas
Modulation of allergic inflammation in mice deficient in TNF receptors
Am J Physiol Lung Cell Mol Physiol, December 1, 2000; 279(6): L1047 - L1057.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
P. J. BARNES, S. PEDERSEN, and W. W. BUSSE
Efficacy and Safety of Inhaled Corticosteroids . New Developments
Am. J. Respir. Crit. Care Med., March 1, 1998; 157(3): S1 - 53.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 1995 American Thoracic Society